The purpose of this test is to select Chinese healthy subjects, take Compound Reserpine Triamterene Capsules provided by Beijing Xinghao Pharmaceutical Co., Ltd. as the test preparation, and according to the relevant BE test regulations, it will be compared with the domestic listed Beijing Shuanghe Compound reserpine triamterene tablets (trade name: No. 0, reference preparation) produced by Pharmaceutical Co., Ltd. were tested for relative bioavailability and bioequivalence in humans, and the relative bioavailability of the test preparation was calculated. The bioequivalence of the two formulations was compared.
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.